Neoantigens as potential vaccines in hepatocellular carcinoma

BACKGROUND: Neoantigens, new immunogenic sequences arising from tumor mutations, have been associated with response to immunotherapy and are considered potential targets for vaccination. Hepatocellular carcinoma (HCC) is a moderately mutated tumor, where the neoantigen repertoire has not been invest...

Descripción completa

Detalles Bibliográficos
Autores principales: Repáraz, David, Ruiz, Marta, Llopiz, Diana, Silva, Leyre, Vercher, Enric, Aparicio, Belén, Egea, Josune, Tamayo-Uria, Ibon, Hervás-Stubbs, Sandra, García-Balduz, Jorge, Castro, Carla, Iñarrairaegui, Mercedes, Tagliamonte, Maria, Mauriello, Angela, Cavalluzzo, Beatrice, Buonaguro, Luigi, Rohrer, Charlotte, Heim, Kathrin, Tauber, Catrin, Hofmann, Maike, Thimme, Robert, Sangro, Bruno, Sarobe, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066373/
https://www.ncbi.nlm.nih.gov/pubmed/35193931
http://dx.doi.org/10.1136/jitc-2021-003978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066373/
https://www.ncbi.nlm.nih.gov/pubmed/35193931
http://dx.doi.org/10.1136/jitc-2021-003978

Ejemplares similares